Maintenance of Platelet Inhibition With Cangrelor

BRIDGE: Maintenance of Platelet inihiBition With cangRelor After dIscontinuation of ThienopyriDines in Patients Undergoing surGEry

The purpose of this study is to demonstrate that patients receiving cangrelor infusion before coronary artery bypass grafting have an acceptable safety profile and can undergo surgery without excessive bleeding peri-operatively.

Inclusion Criteria:

• Written informed consent
• 18 Years of Age
• Non emergent coronary bypass graft surgery
• Received a thienopyridine within 48 hours prior to enrollment

Exclusion Criteria:

• Confirmed or suspected pregnancy
• Cerebrovascular accident within one yar
• Intracranial neoplasm
• History of bleeding diathesis
• Thrombocytopenia